ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug

J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH mid-stage findings for important new medicines.

Ned Pagliarulo, Jonathan Gardner and Ben Fidler Member since December 10, 2024

Loading + Follow Following